PRKD2
Serine/threonine-protein kinase D2
Also known as: DKFZP586E0820, HSPC187, KPCD2_HUMAN, PKD2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZL6
- Gene
- PRKD2
- Ensembl
- ENSG00000105287
- Chromosome
- 19
- Canonical length
- 878 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the protein kinase D (PKD) family of serine/threonine protein kinases. This kinase can be activated by phorbol esters as well as by gastrin via the cholecystokinin B receptor (CCKBR) in gastric cancer cells. It can bind to diacylglycerol (DAG) in the trans-Golgi network (TGN) and may regulate basolateral membrane protein exit from TGN. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
878 residues, UniProt reviewed canonical sequence.
>Q9BZL6|PRKD2
1 MATAPSYPAG LPGSPGPGSP PPPGGLELQS PPPLLPQIPA PGSGVSFHIQ IGLTREFVLL
61 PAASELAHVK QLACSIVDQK FPECGFYGLY DKILLFKHDP TSANLLQLVR SSGDIQEGDL
121 VEVVLSASAT FEDFQIRPHA LTVHSYRAPA FCDHCGEMLF GLVRQGLKCD GCGLNYHKRC
181 AFSIPNNCSG ARKRRLSSTS LASGHSVRLG TSESLPCTAE ELSRSTTELL PRRPPSSSSS
241 SSASSYTGRP IELDKMLLSK VKVPHTFLIH SYTRPTVCQA CKKLLKGLFR QGLQCKDCKF
301 NCHKRCATRV PNDCLGEALI NGDVPMEEAT DFSEADKSAL MDESEDSGVI PGSHSENALH
361 ASEEEEGEGG KAQSSLGYIP LMRVVQSVRH TTRKSSTTLR EGWVVHYSNK DTLRKRHYWR
421 LDCKCITLFQ NNTTNRYYKE IPLSEILTVE SAQNFSLVPP GTNPHCFEIV TANATYFVGE
481 MPGGTPGGPS GQGAEAARGW ETAIRQALMP VILQDAPSAP GHAPHRQASL SISVSNSQIQ
541 ENVDIATVYQ IFPDEVLGSG QFGVVYGGKH RKTGRDVAVK VIDKLRFPTK QESQLRNEVA
601 ILQSLRHPGI VNLECMFETP EKVFVVMEKL HGDMLEMILS SEKGRLPERL TKFLITQILV
661 ALRHLHFKNI VHCDLKPENV LLASADPFPQ VKLCDFGFAR IIGEKSFRRS VVGTPAYLAP
721 EVLLNQGYNR SLDMWSVGVI MYVSLSGTFP FNEDEDINDQ IQNAAFMYPA SPWSHISAGA
781 IDLINNLLQV KMRKRYSVDK SLSHPWLQEY QTWLDLRELE GKMGERYITH ESDDARWEQF
841 AAEHPLPGSG LPTDRDLGGA CPPQDHDMQG LAERISVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- spleen: 47 nTPM
- skin: 41 nTPM
- lung: 30 nTPM
- lymph node: 29 nTPM
- bone marrow: 28 nTPM
- small intestine: 26 nTPM
Single-cell type
- oocytes: 253 nCPM
- neutrophils: 197 nCPM
- foveolar cells: 97 nCPM
- plasma cells: 91 nCPM
- vascular endothelial cells: 88 nCPM
- b-cells: 87 nCPM
Immune cell
- neutrophil: 5.3 nTPM
- memory B-cell: 4.3 nTPM
- memory CD8 T-cell: 4.3 nTPM
- naive B-cell: 4.1 nTPM
- gdT-cell: 3.9 nTPM
- memory CD4 T-cell: 3.9 nTPM
Brain region
- choroid plexus: 28 nTPM
- medulla oblongata: 23 nTPM
- cerebral cortex: 18 nTPM
- thalamus: 18 nTPM
- amygdala: 17 nTPM
- basal ganglia: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.68
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- angiogenesis
- cell adhesion
- cellular response to vascular endothelial growth factor stimulus
- endothelial tube morphogenesis
- intracellular signal transduction
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of angiogenesis
- positive regulation of blood vessel endothelial cell migration
- positive regulation of cell adhesion
- positive regulation of DNA biosynthetic process
- positive regulation of DNA-binding transcription factor activity
- positive regulation of endothelial cell chemotaxis
- positive regulation of endothelial cell migration
- positive regulation of endothelial cell proliferation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of fibroblast growth factor receptor signaling pathway
- positive regulation of interleukin-2 production
- positive regulation of interleukin-8 production
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of T cell receptor signaling pathway
- positive regulation of transcription by RNA polymerase II
- positive regulation of vascular endothelial growth factor receptor signaling pathway
- protein phosphorylation
- regulation of T cell apoptotic process
- sphingolipid biosynthetic process
- T cell receptor signaling pathway
- vascular endothelial growth factor receptor signaling pathway
Molecular functions
- ATP binding
- diacylglycerol-dependent serine/threonine kinase activity
- protein kinase activity
- protein kinase C binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Pleckstrin homology domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- PH-like domain superfamily
- Protein kinase C mu-related
- Protein kinase, ATP binding site
- Diacylglycerol/phorbol-ester binding
- C1-like domain superfamily
- Serine/threonine-protein kinase D1-3-like, ubiquitin-like domain
- Protein kinase domain
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- PH domain
- Serine/threonine-protein kinase D1-like, ubiquitin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKD2 as an antibody target. Whether an autoantibody or antibody against PRKD2 could matter depends on whether native PRKD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKD2 is annotated at the cell surface, where native PRKD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PRKD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...